星盛商業(06668.HK)附屬成立合資提供業物業營運服務
星盛商業(06668.HK)公布,公司間接全資附屬廣州星通與廣州健康城管理訂立合資協議,雙方同意在中國廣州成立一間合資公司,以提供與廣州國際醫藥港購物中心有關的商業物業營運服務。合資公司的註冊資本為3,000萬元人民幣(下同),其中廣州健康城管理及廣州星通將分別出資2,100萬元及900萬元,並將分別向合資公司提供股東貸款7,000萬元及3,000萬元。
合資公司成立後,雙方同意合資公司將向出租人廣東省廣州國際醫藥港(即項目物業的發展商及擁有人,並持有廣州健康城管理全部權益)租用項目物業,為期15年,合資公司其後會與廣州星通簽訂管理協議。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.